Riaz Dawood (South Africa) answers the following questions:
- Please tell us about the prevalence of hypertension and especially resistant hypertension in South Africa
- Who refers the resistant hypertensive patients to you?
- What experience do you have with device-based treatments in South Africa?
- What did you enjoy at the RHC 2014 in Berlin?
- How did the update on the Symplicity HTN-3 trial affect your work?